Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Keytruda
Active Ingredient: Pembrolizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: MSD International GmbH, Carlow, Ireland
   
Product: Nicotrol
Active Ingredient: Nicotine polacrilex 10mg equivalent to nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: JNTL Consumer Health (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
   
Product: Nicotrol
Active Ingredient: Nicotine polacrilex 20mg equivalent to nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: JNTL Consumer Health (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
   
Product: Skyrizi
Active Ingredient: Risankizumab 90.36mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
AbbVie Biotechnology Limited, Barceloneta, Puerto Rico
   
Product:  Zeposia (Combination product)  
Component 1  
Active Ingredient: Ozanimod 0.23mg equivalent to Ozanimod hydrochloride 0.25mg
Dosage Form: Capsule  
Component 2  
Active Ingredient: Ozanimod 0.46mg equivalent to Ozanimod hydrochloride 0.5mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Limited
Manufacturers: Patheon Inc, Mississauga, Canada
Celgene International Sarl, Boudry, Switzerland
   
Product: Zeposia
Active Ingredient: Ozanimod 0.92mg equivalent to Ozanimod hydrochloride 1mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Limited
Manufacturers: Patheon Inc, Mississauga, Canada
Celgene International Sarl, Boudry, Switzerland


Dated this 19th day of May 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).